New malaria drug tested in infants could boost vaccine power
NCT ID NCT06461026
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 31 times
Summary
This study tests a new medicine called L9LS to prevent malaria in infants aged 1 to 12 months in Mali. Researchers want to see if it is safe and how it works in the body, and also if it affects a malaria vaccine given later. About 180 healthy infants will take part, and the study is already active but not recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faladje MRTC Clinic
Faladié, Koulikoro, Mali
-
Kalifabougou MRTC Clinic
Kalifabougou, Koulikoro, Mali
-
Torodo MRTC Clinic
Torodo, Koulikoro, Mali
Conditions
Explore the condition pages connected to this study.